ALZN is trading 5.2% higher at $1.22 in pre-market, extending a rebound after closing at $1.16 on July 03, 2026.
- The move appears to be a continuation of a recent short-term bounce in the micro-cap stock amid generally positive U.S. equity futures.
- There are no fresh company-specific headlines, earnings, FDA actions, or analyst calls reported so far this morning.